Your session is about to expire
← Back to Search
Telehealth Counseling for Alcohol Misuse in HIV (ReACH3 Trial)
N/A
Recruiting
Led By Christopher Kahler, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
ReACH3 Trial Summary
This trial will test whether a counseling program delivered via text messaging and videoconferencing can help reduce alcohol use and improve HIV viral control among people with HIV who drink heavily.
Who is the study for?
This trial is for people with HIV who are receiving care at one of the participating health centers and have a history of heavy drinking, defined as having at least one day with 4+ drinks or averaging more than 7 drinks per week in the last month. Those needing supervised detox due to severe withdrawal symptoms cannot participate.Check my eligibility
What is being tested?
The study is testing if telehealth counseling can help reduce alcohol use and improve HIV viral control. Participants will either get a single session of brief alcohol counseling or that plus a referral to an extended telehealth program with videoconferencing and text support.See study design
What are the potential side effects?
Since this trial involves counseling services rather than medication, there are no direct physical side effects from the interventions being tested. However, participants may experience emotional discomfort discussing personal habits.
ReACH3 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Alcoholics drinks consumed per week
Number of heavy drinking days
Proportion of participants with a detectable HIV viral load
Secondary outcome measures
Condomless sex with non-steady partners
Proportion of the past 30 days adherent to antiretroviral therapy
Veterans Aging Cohort Study (VACS) index total score
ReACH3 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Brief Intervention plus Telehealth CounselingExperimental Treatment3 Interventions
A brief alcohol intervention followed by referral to a telehealth counseling protocol including 5 sessions of counseling based on Motivational Interviewing and delivered by videoconferencing. Telehealth counseling extends for up to two years and also includes a text messaging intervention to encourage reductions in drinking.
Group II: Brief interventionActive Control1 Intervention
A brief alcohol intervention lasting about 10 minutes, delivered after the baseline assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brief Intervention
2008
Completed Phase 3
~5860
Text messaging
2013
Completed Phase 4
~238080
Find a Location
Who is running the clinical trial?
Brown UniversityLead Sponsor
456 Previous Clinical Trials
557,754 Total Patients Enrolled
Christopher Kahler, PhDPrincipal InvestigatorBrown University School of Public Health
1 Previous Clinical Trials
271 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of severe alcohol withdrawal symptoms, like seizures and delirium tremens, that require supervised medical treatment.If you receive HIV care at one of the 4 participating health centers, and you have had at least one day in the past month where you drank heavily (4 or more drinks), or if you drink more than 7 drinks per week on average.
Research Study Groups:
This trial has the following groups:- Group 1: Brief Intervention plus Telehealth Counseling
- Group 2: Brief intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment underway for this research endeavor?
"According to clinicaltrials.gov, this medical trial is still enrolling eligible participants; it was initially advertised on June 22nd 2021 and the most recent update occurred on March 28th 2022."
Answered by AI
To what extent is the participant intake of this research project?
"Yes, the evidence on clinicaltrials.gov implies that this experiment is currently recruiting participants. First published in June of 2021 and last edited in March 2022, this trial seeks 600 individuals from a single medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger